Turbare Manufacturing 2025-03-05 Health serious FDA
Health · FDA · Recall #FDA-D-0248-2025
Avastin 1.25 mg/0.05 mL in 0.25 mL Syringe, For Intravitreal Injection Only, Office Use… Recall
Issued March 5, 2025 · Turbare Manufacturing
In March 2025, Turbare Manufacturing recalled the Avastin 1.25 mg/0.05 mL in 0.25 mL Syringe, For Intravitreal Injection Only, Office Use…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Lack of Assurance of Sterility: due to a quality control process deviation
What you should do
- 1 Stop using Avastin 1.25 mg/0.05 mL in 0.25 mL Syringe, For Intravitreal Injection Only, Office Use… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Turbare Manufacturing to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Turbare Manufacturing
- Category
- Health
- Recall date
- March 5, 2025
- Units affected
- Not reported
- Sold at
- Nationwide in the USA
- Recall number
- FDA-D-0248-2025
- Made in
- United States
- Issuing agency
- FDA
In context
- Turbare Manufacturing has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 691st Health recall we've logged in 2025.